By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atrium Innovations 

1405 boul. du Parc-Technologique

Quebec City  Quebec  G1P 4P5  Canada
Phone: 418-652-1116 Fax: 418-652-0151


Medical Device

Company News
Atrium Innovations Release: Promising New Findings Demonstrate The Efficacy Of DHA And EPA In The Fight Against Chronic Disease 4/25/2017 9:10:15 AM
Atrium Innovations Release: New Clinical Trial Shows Uniquely-Derived Strawberry And Cranberry Polyphenols May Improve Insulin Sensitivity For People With Pre-Diabetes 4/7/2017 10:06:12 AM
Atrium Innovations Release: Clinical Trial Shows Wobenzym Has A Significant Effect On Exercise-Induced Fatigue, Muscle Soreness And Damage In Endurance Athletes 3/14/2017 6:37:30 AM
Atrium Innovations Release: New Research Highlights Efficacy Of Oral Enzyme Combination Over NSAID In Treatment Of Osteoarthritis 11/8/2016 12:19:11 PM
Atrium Innovations Is BÉNÉFIQ's 2014 Diamond Sponsor 6/26/2014 8:14:33 AM
Atrium Innovations Names Peter Luther President And Chief Executive Officer 6/6/2014 6:18:35 AM
Atrium Innovations Announces Management Transition 4/8/2014 9:24:56 AM
Atrium Innovations Acquires 70% of Mucos Pharma CZ, Distributor of Wobenzym® Products in Central and Eastern Europe 10/8/2013 9:31:17 AM
Atrium Innovations Announces 2013 Second Quarter Financial Results 8/12/2013 8:30:22 AM
Media Advisory - Atrium Innovations to Present at the Canaccord Genuity 33rd Annual Growth Conference on August 14, 2013 8/5/2013 8:23:42 AM